Skip to main content

Advertisement

Springer Nature Link
Log in

Periostin gene polymorphisms, protein levels and risk of incident coronary artery disease

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Vascular endothelial growth factor and its receptor the kinase domain receptor play critical roles in the pathogenesis of coronary artery disease. Periostin is an up-regulator of kinase domain receptor expression. The purpose of this study was to determine whether polymorphisms in periostin are associated with the risk of coronary artery disease. Two single nucleotide polymorphisms (SNP C-33G, SNP A-953T) within the promoter region were chosen for further analyses. A case–control study was carried out with patients of Han Chinese ethnicity, which consisted of 492 coronary artery disease cases and 498 controls. Genotyping was performed by means of PCR and restriction fragment length polymorphism (PCR–RFLP) and the plasma level of periostin was measured by enzyme-linked immunosorbent assay (ELISA). In our study, the TT genotype of SNP-A953T was present in the general Chinese population (3.5%), but not in the Han Chinese from Beijing Project (HAPMAP CHB). Plasma periostin concentrations were elevated significantly in patients with coronary artery disease (7.96 ± 8.33 nmol/l) compared with those in healthy volunteers (3.93 ± 1.71 nmol/l) (P = 0.005). There was a significant correlation between the 953T genotype and the plasma level of periostin (r 2 = −0.490, P = 0.039). The prevalence of the TT genotype in patients was associated with a slightly lower risk of coronary artery disease (OR = 0.443, 95% CI = 0.200–0.982), but was not significant after correction (OR = 0.427, 95% CI = 0.146–1.250). The periostin-33G allele frequency was not significantly different in cases versus controls. Our data suggest that plasma periostin level may serve as a biomarker for the risk of coronary artery disease, but the periostin polymorphisms SNPC-33G and SNPA-953T were not significantly associated with the risk of coronary artery disease in this Chinese population. Although a major effect of the SNPs in the periostin genes on coronary artery disease susceptibility was excluded, the effect of the A-953T SNP on susceptibility and protein expression needs further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Silverstein RL, Nachman RL (1999) Angiogenesis and atherosclerosis. The mandate broadens. Circulation 100:783–785. doi:10.1046/j.1365-2168.1999.0707c.x

    PubMed  CAS  Google Scholar 

  2. Khurana R, Simons M, Martin JF, Zachary IC (2005) Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112:1813–1824. doi:10.1161/CIRCULATIONAHA.105.535294

    Article  PubMed  Google Scholar 

  3. Emanueli C, Madeddu P (2001) Angiogenesis gene therapy to rescue ischaemic tissues: achievements and future directions. Br J Pharmacol 133:951–958. doi:10.1038/sj.bjp.0704155

    Article  PubMed  CAS  Google Scholar 

  4. Doyle B, Caplice N (2007) Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 49:2073–2080. doi:10.1016/j.jacc.2007.01.089

    Article  PubMed  Google Scholar 

  5. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66. doi:10.1038/376062a0

    Article  PubMed  CAS  Google Scholar 

  6. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y et al (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767. doi:10.1016/j.jacc.2007.04.074

    Article  PubMed  CAS  Google Scholar 

  7. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T (2007) Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 22:1167–1174

    PubMed  CAS  Google Scholar 

  8. Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H et al (2004) Expression and function of periostin-isoforms in bone. J Cell Biochem 92:1044–1061. doi:10.1002/jcb.20115

    Article  PubMed  CAS  Google Scholar 

  9. Bagnato C, Thumar J, Mayya V, Hwang SI, Zebroski H, Claffey KP et al (2007) Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 6:1088–1102. doi:10.1074/mcp.M600259-MCP200

    Article  PubMed  CAS  Google Scholar 

  10. Shao R, Guo X (2004) Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun 321:788–794. doi:10.1016/j.bbrc.2004.07.033

    Article  PubMed  CAS  Google Scholar 

  11. Forsti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K et al (2007) Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 101:83–93. doi:10.1007/s10549-006-9265-1

    Article  PubMed  Google Scholar 

  12. 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention (2008) A report of the American college of cardiology/American heart association task force on practice guidelines. Catheter Cardiovasc Interv 71:E1–E40. doi:10.1161/CIRCULATIONAHA.107.188208

    Google Scholar 

  13. Fraker TD Jr, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J et al (2007) 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American college of cardiology/American heart association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 50:2264–2274. doi:10.1016/j.jacc.2007.08.002

    Article  PubMed  Google Scholar 

  14. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non st-elevation myocardial infarction: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non st-elevation myocardial infarction): developed in collaboration with the american college of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: endorsed by the american association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation 116:e148–e304. doi:10.1016/j.jacc.2007.02.028

    Article  PubMed  Google Scholar 

  15. Bates ER (2008) 2007 focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Pol Arch Med Wewn 118:88–89. doi:10.1016/j.jacc.2007.10.001

    PubMed  Google Scholar 

  16. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC et al (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113:2363–2372. doi:10.1161/CIRCULATIONAHA.106.174516

    Article  PubMed  Google Scholar 

  17. Whitworth JA (2003) 2003 World Health Organization (WHO)/international society of hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983–1992. doi:10.1097/00004872-200311000-00002

    Article  PubMed  Google Scholar 

  18. Jorgensen LG, Brandslund I, Petersen PH, Olivarius Nde F, Stahl M (2003) The effect of the new ADA and WHO guidelines on the number of diagnosed cases of diabetes mellitus. Clin Chem Lab Med 41:1246–1250. doi:10.1515/CCLM.2003.191

    Article  PubMed  CAS  Google Scholar 

  19. Lahiri DK, Bye S, Nurnberger JI Jr, Hodes ME, Crisp M (1992) A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods 25:193–205. doi:10.1016/0165-022X(92)90014-2

    Article  PubMed  CAS  Google Scholar 

  20. Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F, Yuan YZ (2009) Circulating levels of periostin may help identify patients with more aggressive colorectal cancer. Int J Oncol 34:821–828. doi:10.3892/ijo_00000208

    PubMed  CAS  Google Scholar 

  21. Ding K, Zhou K, He F, Shen Y (2003) LDA—a java-based linkage disequilibrium analyzer. Bioinformatics (Oxford, England) 19:2147–2148. doi:10.1093/bioinformatics/btg276

    Article  CAS  Google Scholar 

  22. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978–989. doi:10.1086/319501

    Article  PubMed  CAS  Google Scholar 

  23. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169. doi:10.1086/379378

    Article  PubMed  CAS  Google Scholar 

  24. Sasaki H, Dai M, Auclair D, Fukai I, Kiriyama M, Yamakawa Y et al (2001) Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92:843–848. doi:10.1002/1097-0142(20010815)92:4<843:AID-CNCR1391>3.0.CO;2-P

    Article  PubMed  CAS  Google Scholar 

  25. Sasaki H, Dai M, Auclair D, Kaji M, Fukai I, Kiriyama M et al (2001) Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett 172:37–42. doi:10.1016/S0304-3835(01)00633-4

    Article  PubMed  CAS  Google Scholar 

  26. Sasaki H, Yu CY, Dai M, Tam C, Loda M, Auclair D et al (2003) Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat 77:245–252. doi:10.1023/A:1021899904332

    Article  PubMed  CAS  Google Scholar 

  27. Takeshita S, Kikuno R, Tezuka K, Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294(Pt 1):271–278

    PubMed  CAS  Google Scholar 

  28. Kruzynska-Frejtag A, Wang J, Maeda M, Rogers R, Krug E, Hoffman S et al (2004) Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn 229:857–868. doi:10.1002/dvdy.10453

    Article  PubMed  CAS  Google Scholar 

  29. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP (2005) Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 25:77–83. doi:10.1161/01.ATV.0000149141.81230.c6

    PubMed  CAS  Google Scholar 

  30. Li P, Oparil S, Feng W, Chen YF (2004) Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physio l97:1550–1558. doi:10.1152/japplphysiol.01311.2003 discussion 1549

    Article  Google Scholar 

  31. Puglisi F, Puppin C, Pegolo E, Andreetta C, Pascoletti G, D’Aurizio F et al (2008) Expression of periostin in human breast cancer. J Clin Pathol 61:494–498. doi:10.1136/jcp.2007.052506

    Article  PubMed  CAS  Google Scholar 

  32. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25. doi:10.1210/er.18.1.4

    Article  PubMed  CAS  Google Scholar 

  33. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39:469–478

    Article  PubMed  CAS  Google Scholar 

  34. Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66–70. doi:10.1038/376066a0

    Article  PubMed  CAS  Google Scholar 

  35. Matsumoto T, Claesson-Welsh L (2001) VEGF receptor signal transduction. Sci STKE2001:RE 21. doi:10.1126/stke.2001.112.re21

Download references

Acknowledgments

We wish to thank all the participants in this study. This study was supported by research grants from “the Technology Project of Changzhou Social Development” (CS20092018).

Author information

Authors and Affiliations

  1. Department of Cardiovascular Disease, Changzhou Second People’s Hospital, Affiliated Nanjing Medical University, Changzhou, 213003, Jiangsu, China

    Fangfang Wang, Cuan Yang, Ying Song, Ye Jiang & Zhijian Ding

Authors
  1. Fangfang Wang
    View author publications

    Search author on:PubMed Google Scholar

  2. Cuan Yang
    View author publications

    Search author on:PubMed Google Scholar

  3. Ying Song
    View author publications

    Search author on:PubMed Google Scholar

  4. Ye Jiang
    View author publications

    Search author on:PubMed Google Scholar

  5. Zhijian Ding
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Zhijian Ding.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, F., Yang, C., Song, Y. et al. Periostin gene polymorphisms, protein levels and risk of incident coronary artery disease. Mol Biol Rep 39, 359–367 (2012). https://doi.org/10.1007/s11033-011-0746-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-0746-x

Keywords